Search research articles
Contact Us
Filters
Showing results (51-60 of 127) with videos related to
Page
of 13
Sort By:
Current Opinion in Gastroenterology
|
March 14, 2019
Tools for causality assessment in drug-induced liver disease
Hans L Tillmann, Ayako Suzuki, Huiman X Barnhart, et al.
AIDS (London, England)
|
April 20, 2002
Chemokine receptor polymorphisms and GB virus C status in HIV-positive patients
Hans L Tillmann, Matthias Stoll, Michael P Manns, et al.
Alimentary Pharmacology & Therapeutics
|
March 10, 2022
A novel phenotype-based drug-induced liver injury causality assessment tool (DILI-CAT) allows for signal confirmation in early drug development
Richard P Hermann, Don C Rockey, Ayako Suzuki, et al.
Gastroenterology & Hepatology
|
February 3, 2012
Etanercept treatment to enable successful hepatitis C virus clearance in a patient with rheumatoid arthritis
Alison B Jazwinski, Janet Jezsik, Stacy P Ardoin, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
November 16, 2002
[Prevalence of circulating autoantibodies in healthy individuals]
Andreas Teubner, Hans L Tillmann, Detlef Schuppan, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
October 25, 2017
Curing hepatitis C virus (HCV) after organ transplantation: Increased risk of rejection following HCV elimination
George Kasarala, Steve Choi, Katie Lopez, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
October 17, 2007
Improvement of multiple sclerosis on tacrolimus plus mycophenolate mofetil after liver transplantation. Clinical improvement of multiple sclerosis in a patient requiring liver transplantation for acute liver failure following interferon-beta therapy
Julia Behrbohm, Matthias Neid, Ulrich Stölzel, et al.
Journal of Medical Virology
|
March 12, 2003
GB virus C genotype determination in GB virus-C/HIV co-infected individuals
A Scott Muerhoff, Hans L Tillmann, Michael P Manns, et al.
Journal of Medical Virology
|
June 2, 2004
High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection
Marc Lehmann, Manuela F Meyer, Masyar Monazahian, et al.
European Journal of Medical Research
|
November 15, 2006
Differential influence of different hepatitis viruses on quality of life in HIV positive patients
Hans L Tillmann, T Kaiser, C Claes, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 127) with videos related to
Sort By:
Page
of 13
Current Opinion in Gastroenterology
|
March 14, 2019
Tools for causality assessment in drug-induced liver disease
Hans L Tillmann, Ayako Suzuki, Huiman X Barnhart, et al.
AIDS (London, England)
|
April 20, 2002
Chemokine receptor polymorphisms and GB virus C status in HIV-positive patients
Hans L Tillmann, Matthias Stoll, Michael P Manns, et al.
Alimentary Pharmacology & Therapeutics
|
March 10, 2022
A novel phenotype-based drug-induced liver injury causality assessment tool (DILI-CAT) allows for signal confirmation in early drug development
Richard P Hermann, Don C Rockey, Ayako Suzuki, et al.
Gastroenterology & Hepatology
|
February 3, 2012
Etanercept treatment to enable successful hepatitis C virus clearance in a patient with rheumatoid arthritis
Alison B Jazwinski, Janet Jezsik, Stacy P Ardoin, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
November 16, 2002
[Prevalence of circulating autoantibodies in healthy individuals]
Andreas Teubner, Hans L Tillmann, Detlef Schuppan, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
October 25, 2017
Curing hepatitis C virus (HCV) after organ transplantation: Increased risk of rejection following HCV elimination
George Kasarala, Steve Choi, Katie Lopez, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
October 17, 2007
Improvement of multiple sclerosis on tacrolimus plus mycophenolate mofetil after liver transplantation. Clinical improvement of multiple sclerosis in a patient requiring liver transplantation for acute liver failure following interferon-beta therapy
Julia Behrbohm, Matthias Neid, Ulrich Stölzel, et al.
Journal of Medical Virology
|
March 12, 2003
GB virus C genotype determination in GB virus-C/HIV co-infected individuals
A Scott Muerhoff, Hans L Tillmann, Michael P Manns, et al.
Journal of Medical Virology
|
June 2, 2004
High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection
Marc Lehmann, Manuela F Meyer, Masyar Monazahian, et al.
European Journal of Medical Research
|
November 15, 2006
Differential influence of different hepatitis viruses on quality of life in HIV positive patients
Hans L Tillmann, T Kaiser, C Claes, et al.
Page
of 13